Page last updated: 2024-08-26

equol and Angiogenesis, Pathologic

equol has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adlercreutz, H; Al-Maharik, N; Bagli, E; Bellou, S; Fotsis, T; Karali, E; Morbidelli, L; Murphy, C; Ziche, M	1

Other Studies

1 other study(ies) available for equol and Angiogenesis, Pathologic

Article	Year
The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth. Molecular cancer, 2012, May-14, Volume: 11 Topics: Angiogenesis Inhibitors; Animals; Cattle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Equol; Female; Human Umbilical Vein Endothelial Cells; Humans; Isoflavones; MAP Kinase Signaling System; Mice; Mice, Nude; Mitosis; Neoplasms; Neovascularization, Pathologic; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2012

Article

Year

The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth.

Molecular cancer, 2012, May-14, Volume: 11

Topics: Angiogenesis Inhibitors; Animals; Cattle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Equol; Female; Human Umbilical Vein Endothelial Cells; Humans; Isoflavones; MAP Kinase Signaling System; Mice; Mice, Nude; Mitosis; Neoplasms; Neovascularization, Pathologic; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2012